Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

BACKGROUND: Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. METHODS: Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Particip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ERJ Open Res
Main Authors: Gibson, Peter G., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Powell, Heather, Simpson, Jodie L.
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6926362/
https://ncbi.nlm.nih.gov/pubmed/31886156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00056-2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados